A September Skip, The Bullish Case for Viking Therapeutics, and Lassoing the Laggards 8/19/25

A September Skip, The Bullish Case for Viking Therapeutics, and Lassoing the Laggards 8/19/25

  • Höfundur
  • Episode
      1531
  • Published
      19 aug. 2025
  • Útgefandi
0 Umsagnir
0
Episode
1531 of 1586
Lengd
44Mín.
Tungumál
enska
Gerð
Flokkur
Viðskiptabækur

Why the Fed could skip a September cut altogether, despite higher inflation data. BTIG makes the case for sticking with Viking Therapeutics despite disappointing weight loss drug trial data. Plus, the laggards our traders says to buy now.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


Hlustaðu og lestu

Stígðu inn í heim af óteljandi sögum

  • Lestu og hlustaðu eins mikið og þú vilt
  • Þúsundir titla
  • Getur sagt upp hvenær sem er
  • Engin skuldbinding
Prófa frítt
is Device Banner Block 894x1036
Cover for A September Skip, The Bullish Case for Viking Therapeutics, and Lassoing the Laggards 8/19/25

Other podcasts you might like ...